The campaign group Forska!Sverige has taken the Swedish government to task over its spending on medical research.
In the Swedish current affairs magazine Dagens Samhälle, Anna Nilsson Vindefjärd and Olle Stendahl of the organisation castigated the government for contributing to trends they described as “worrying”.
A Forska!Sverige report published this month found that government investment in R&D continues to decline in relation to Sweden’s GDP. In addition, the proportion of full-time R&D jobs in Swedish pharmaceutical companies has decreased by 61.8 per cent in 10 years and Swedish clinical drug trials fell by half between 2004 and 2017, the report showed.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.